Bank of America Corp DE lowered its stake in Lantheus Holdings, Inc. (NASDAQ:LNTH) by 4.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 67,633 shares of the medical equipment provider’s stock after selling 3,070 shares during the period. Bank of America Corp DE owned about 0.18% of Lantheus Holdings worth $845,000 as of its most recent filing with the SEC.
Other institutional investors also recently bought and sold shares of the company. Systematic Financial Management LP bought a new position in Lantheus Holdings during the first quarter valued at about $1,314,000. ClariVest Asset Management LLC raised its position in Lantheus Holdings by 20.1% in the first quarter. ClariVest Asset Management LLC now owns 154,346 shares of the medical equipment provider’s stock valued at $1,930,000 after buying an additional 25,859 shares during the last quarter. Spark Investment Management LLC raised its position in Lantheus Holdings by 129.0% in the first quarter. Spark Investment Management LLC now owns 300,900 shares of the medical equipment provider’s stock valued at $3,761,000 after buying an additional 169,500 shares during the last quarter. Mckinley Capital Management LLC Delaware raised its position in Lantheus Holdings by 109.4% in the first quarter. Mckinley Capital Management LLC Delaware now owns 281,221 shares of the medical equipment provider’s stock valued at $3,515,000 after buying an additional 146,936 shares during the last quarter. Finally, Nordea Investment Management AB raised its position in Lantheus Holdings by 23.7% in the first quarter. Nordea Investment Management AB now owns 127,700 shares of the medical equipment provider’s stock valued at $1,596,000 after buying an additional 24,500 shares during the last quarter. Institutional investors own 71.53% of the company’s stock.
Lantheus Holdings, Inc. (NASDAQ LNTH) traded up 3.55% during midday trading on Tuesday, reaching $16.05. The company’s stock had a trading volume of 173,517 shares. Lantheus Holdings, Inc. has a 52-week low of $6.63 and a 52-week high of $20.45. The firm has a market cap of $599.47 million, a P/E ratio of 21.93 and a beta of 0.91. The firm has a 50 day moving average of $17.94 and a 200 day moving average of $14.63.
Lantheus Holdings (NASDAQ:LNTH) last announced its quarterly earnings data on Tuesday, August 1st. The medical equipment provider reported $0.42 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.24 by $0.18. Lantheus Holdings had a net margin of 8.44% and a negative return on equity of 37.47%. The business had revenue of $88.83 million for the quarter, compared to analyst estimates of $80.56 million. During the same period last year, the business earned $0.24 EPS. The company’s revenue was up 13.9% on a year-over-year basis. Analysts anticipate that Lantheus Holdings, Inc. will post $1.12 earnings per share for the current fiscal year.
Several research firms have recently issued reports on LNTH. Jefferies Group LLC restated a “buy” rating and set a $22.00 target price (up from $18.00) on shares of Lantheus Holdings in a research report on Wednesday, August 2nd. Cantor Fitzgerald initiated coverage on Lantheus Holdings in a report on Monday, July 17th. They set an “overweight” rating and a $22.00 price objective on the stock. Zacks Investment Research cut Lantheus Holdings from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 5th. BidaskClub cut Lantheus Holdings from a “strong-buy” rating to a “buy” rating in a report on Thursday, August 17th. Finally, Credit Suisse Group lifted their price objective on Lantheus Holdings from $14.00 to $19.00 and gave the company a “neutral” rating in a report on Wednesday, August 2nd. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $18.60.
In other news, CEO Mary Anne Heino sold 10,000 shares of the firm’s stock in a transaction on Monday, June 12th. The shares were sold at an average price of $15.39, for a total value of $153,900.00. Following the sale, the chief executive officer now directly owns 602,468 shares in the company, valued at approximately $9,271,982.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director David F. Burgstahler sold 3,000,000 shares of the firm’s stock in a transaction on Tuesday, June 20th. The shares were sold at an average price of $14.87, for a total transaction of $44,610,000.00. The disclosure for this sale can be found here. Insiders sold a total of 3,321,692 shares of company stock worth $50,117,821 over the last 90 days. Company insiders own 2.30% of the company’s stock.
Lantheus Holdings Company Profile
Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.
Want to see what other hedge funds are holding LNTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lantheus Holdings, Inc. (NASDAQ:LNTH).
Receive News & Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.